{"id":33691,"title":"The use of magnetic resonance imaging in the obstetric patient.","abstract":"Objectif : Analyser les effets biologiques et l’innocuité de l’imagerie par résonance magnétique (IRM) chez les patientes en obstétrique et passer en revue les questions relatives à la marche à suivre, ainsi que les indications et les contre-indications propres à l’IRM dans le domaine de l’obstétrique. Issues : La présente directive clinique a pour but de rassurer les patientes et les cliniciens quant à l’innocuité de l’IRM pendant la grossesse, et de fournir un cadre de référence pour son utilisation. Résultats : La littérature publiée a été récupérée par l’intermédiaire de recherches menées dans PubMed ou Medline en 2013 au moyen d’un vocabulaire contrôlé et de mots clés appropriés (p. ex. « MRI », « safety », « pregnancy »). Les résultats ont été restreints aux analyses systématiques, aux essais comparatifs randomisés / essais cliniques comparatifs et aux études observationnelles rédigés en anglais et en français. Aucune restriction n’a été appliquée en matière de dates. Les recherches ont été mises à jour de façon régulière et intégrées à la directive clinique jusqu’en juillet 2013. La littérature grise (non publiée) a été identifiée par l’intermédiaire de recherches menées dans les sites Web d’organismes s’intéressant à l’évaluation des technologies dans le domaine de la santé et d’organismes connexes, dans des collections de directives cliniques, dans des registres d’essais cliniques et auprès de sociétés de spécialité médicale nationales et internationales. Valeurs : La qualité des résultats est évaluée au moyen des critères décrits dans le rapport du Groupe d’étude canadien sur les soins de santé préventifs (Tableau). Avantages, désavantages et coûts : La présente directive clinique a pour but de rassurer les fournisseurs de soins obstétricaux en leur réaffirmant que, lorsqu’elle est utilisée de façon appropriée sans avoir recours à des produits de contraste, l’IRM s’avère sûre pour la mère et le fœtus aux deuxième et troisième trimestres. La présente directive clinique vise à favoriser l’utilisation judicieuse de l’IRM dans le domaine de l’obstétrique, et ce, en raison des coûts mis en cause et du caractère limité de sa disponibilité au Canada. Déclarations sommaires 1. Pour ce qui est du fœtus, le recours à l’imagerie par résonance magnétique est sûre à 3,0 tesla ou moins au cours des deuxième et troisième trimestres. (II-2) 2. La poursuite de l’allaitement à la suite de l’administration d’un produit de contraste à base de gadolinium constitue une pratique sûre. (III) Recommandations 1. L’utilisation de l’imagerie par résonance magnétique au cours du premier trimestre de la grossesse devrait être restreinte aux indications maternelles pour lesquelles les données pouvant ainsi être obtenues sont considérées comme étant impératives sur le plan clinique. L’exposition par inadvertance à l’imagerie par résonance magnétique au cours du premier trimestre n’a été associée à aucune séquelle à long terme et ne devrait pas susciter de préoccupations sur le plan clinique. (III-C) 2. Le gadolinium peut être utilisé à titre de produit de contraste chez les femmes enceintes lorsque les avantages l’emportent sur les risques potentiels. (III-C).To review the biological effects and safety of magnetic resonance imaging (MRI) in the obstetric patient and to review procedural issues, indications, and contraindications for obstetrical MRI.This guideline is intended to reassure patients and clinicians of the safety of MRI in pregnancy and to provide a framework for its use.Published literature was retrieved through searches of PubMed or Medline in 2013 using controlled vocabulary and key words (e.g., MRI, safety, pregnancy). Results were restricted to systematic reviews, randomized control trials/controlled clinical trials, and observational studies published in English and in French. There were no date restrictions. Searches were updated on a regular basis and incorporated in the guideline to July 2013. Grey (unpublished) literature was identified through searching the websites of health technology assessment and health technology-related agencies, clinical practice guideline collections, clinical trial registries, and national and international medical specialty societies.The quality of evidence in this document was rated using the criteria described in the Report of the Canadian Task Force on Preventive Health Care (Table).This article is intended to reassure obstetric care providers that if used in an appropriate manner without the use of contrast agents, MRI in the obstetrical patient is safe for mother and fetus in the second and third trimesters. Because obstetrical MRI is expensive and has limited availability in Canada, this clinical guideline is intended to encourage the judicious use of this resource. SUMMARY STATEMENTS: 1. Fetal magnetic resonance imaging is safe at 3.0 tesla or less during the second and third trimesters. (II-2) 2. It is safe to continue breastfeeding after receiving a gadolinium contrast agent. (III) RECOMMENDATIONS: 1. Use of magnetic resonance imaging during the first trimester of pregnancy should be restricted to maternal indications for which the information is considered clinically imperative. Inadvertent exposure to magnetic resonance imaging during the first trimester has not been associated with any long-term sequelae and should not raise clinical concern. (III-C) 2. Gadolinium contrast may be used in pregnant women when the benefits outweigh the potential risks. (III-C).","date":"2014-05-06","categories":"Congenital Hereditary and Neonatal Diseases and Abnormalities","split":"train","url":"http://www.ncbi.nlm.nih.gov/pubmed/24798674","annotations":[{"name":"Medical guideline","weight":0.896008,"wikipedia_article":"http://en.wikipedia.org/wiki/Medical_guideline"},{"name":"Magnetic resonance imaging","weight":0.851987,"wikipedia_article":"http://en.wikipedia.org/wiki/Magnetic_resonance_imaging"},{"name":"Pregnancy","weight":0.818686,"wikipedia_article":"http://en.wikipedia.org/wiki/Pregnancy"},{"name":"Fetus","weight":0.799906,"wikipedia_article":"http://en.wikipedia.org/wiki/Fetus"},{"name":"Clinical trial","weight":0.792698,"wikipedia_article":"http://en.wikipedia.org/wiki/Clinical_trial"},{"name":"Medicine","weight":0.754651,"wikipedia_article":"http://en.wikipedia.org/wiki/Medicine"},{"name":"Obstetrics","weight":0.74384,"wikipedia_article":"http://en.wikipedia.org/wiki/Obstetrics"},{"name":"Systematic review","weight":0.733635,"wikipedia_article":"http://en.wikipedia.org/wiki/Systematic_review"},{"name":"Breastfeeding","weight":0.726404,"wikipedia_article":"http://en.wikipedia.org/wiki/Breastfeeding"},{"name":"Health care","weight":0.703484,"wikipedia_article":"http://en.wikipedia.org/wiki/Health_care"},{"name":"Health","weight":0.683165,"wikipedia_article":"http://en.wikipedia.org/wiki/Health"},{"name":"Biology","weight":0.680329,"wikipedia_article":"http://en.wikipedia.org/wiki/Biology"},{"name":"Specialty (medicine)","weight":0.667473,"wikipedia_article":"http://en.wikipedia.org/wiki/Specialty_(medicine)"},{"name":"PubMed","weight":0.633774,"wikipedia_article":"http://en.wikipedia.org/wiki/PubMed"},{"name":"Patient","weight":0.629712,"wikipedia_article":"http://en.wikipedia.org/wiki/Patient"},{"name":"Contraindication","weight":0.557965,"wikipedia_article":"http://en.wikipedia.org/wiki/Contraindication"},{"name":"Medical imaging","weight":0.503424,"wikipedia_article":"http://en.wikipedia.org/wiki/Medical_imaging"},{"name":"Society","weight":0.479468,"wikipedia_article":"http://en.wikipedia.org/wiki/Society"},{"name":"Canada","weight":0.47816,"wikipedia_article":"http://en.wikipedia.org/wiki/Canada"},{"name":"Randomized controlled trial","weight":0.451613,"wikipedia_article":"http://en.wikipedia.org/wiki/Randomized_controlled_trial"},{"name":"Clinic","weight":0.445085,"wikipedia_article":"http://en.wikipedia.org/wiki/Clinic"},{"name":"Technology","weight":0.418173,"wikipedia_article":"http://en.wikipedia.org/wiki/Technology"},{"name":"Observational study","weight":0.300935,"wikipedia_article":"http://en.wikipedia.org/wiki/Observational_study"},{"name":"MEDLINE","weight":0.282569,"wikipedia_article":"http://en.wikipedia.org/wiki/MEDLINE"},{"name":"France","weight":0.245927,"wikipedia_article":"http://en.wikipedia.org/wiki/France"},{"name":"Tesla (unit)","weight":0.218337,"wikipedia_article":"http://en.wikipedia.org/wiki/Tesla_(unit)"},{"name":"Literature","weight":0.169122,"wikipedia_article":"http://en.wikipedia.org/wiki/Literature"},{"name":"Hypothermia","weight":0.143971,"wikipedia_article":"http://en.wikipedia.org/wiki/Hypothermia"},{"name":"Contrast medium","weight":0.128079,"wikipedia_article":"http://en.wikipedia.org/wiki/Contrast_medium"},{"name":"English language","weight":0.125212,"wikipedia_article":"http://en.wikipedia.org/wiki/English_language"},{"name":"Information","weight":0.0805305,"wikipedia_article":"http://en.wikipedia.org/wiki/Information"},{"name":"Evidence","weight":0.070554,"wikipedia_article":"http://en.wikipedia.org/wiki/Evidence"},{"name":"Safety","weight":0.055541,"wikipedia_article":"http://en.wikipedia.org/wiki/Safety"},{"name":"World Wide Web","weight":0.0391252,"wikipedia_article":"http://en.wikipedia.org/wiki/World_Wide_Web"},{"name":"Website","weight":0.0391252,"wikipedia_article":"http://en.wikipedia.org/wiki/Website"},{"name":"Maternal bond","weight":0.0391252,"wikipedia_article":"http://en.wikipedia.org/wiki/Maternal_bond"},{"name":"Vocabulary","weight":0.0355959,"wikipedia_article":"http://en.wikipedia.org/wiki/Vocabulary"},{"name":"Magnetism","weight":0.0352321,"wikipedia_article":"http://en.wikipedia.org/wiki/Magnetism"},{"name":"Observation","weight":0.0311179,"wikipedia_article":"http://en.wikipedia.org/wiki/Observation"},{"name":"Woman","weight":0.0311179,"wikipedia_article":"http://en.wikipedia.org/wiki/Woman"},{"name":"Trial","weight":0.0301868,"wikipedia_article":"http://en.wikipedia.org/wiki/Trial"},{"name":"Fortification","weight":0.0300804,"wikipedia_article":"http://en.wikipedia.org/wiki/Fortification"},{"name":"Gadolinium","weight":0.0297972,"wikipedia_article":"http://en.wikipedia.org/wiki/Gadolinium"},{"name":"Technology assessment","weight":0.0297972,"wikipedia_article":"http://en.wikipedia.org/wiki/Technology_assessment"},{"name":"Health technology assessment","weight":0.0297972,"wikipedia_article":"http://en.wikipedia.org/wiki/Health_technology_assessment"},{"name":"Sequela","weight":0.0284659,"wikipedia_article":"http://en.wikipedia.org/wiki/Sequela"},{"name":"Gram","weight":0.0280659,"wikipedia_article":"http://en.wikipedia.org/wiki/Gram"},{"name":"International","weight":0.0280659,"wikipedia_article":"http://en.wikipedia.org/wiki/International"},{"name":"Resonance","weight":0.0206987,"wikipedia_article":"http://en.wikipedia.org/wiki/Resonance"},{"name":"Directive (European Union)","weight":0.0206987,"wikipedia_article":"http://en.wikipedia.org/wiki/Directive_(European_Union)"},{"name":"Tonne","weight":0.0185779,"wikipedia_article":"http://en.wikipedia.org/wiki/Tonne"},{"name":"Clinical psychology","weight":0.0185779,"wikipedia_article":"http://en.wikipedia.org/wiki/Clinical_psychology"},{"name":"Espionage","weight":0.0168623,"wikipedia_article":"http://en.wikipedia.org/wiki/Espionage"},{"name":"Availability","weight":0.0168623,"wikipedia_article":"http://en.wikipedia.org/wiki/Availability"},{"name":"French Canadian","weight":0.0168623,"wikipedia_article":"http://en.wikipedia.org/wiki/French_Canadian"},{"name":"Task force","weight":0.0168623,"wikipedia_article":"http://en.wikipedia.org/wiki/Task_force"},{"name":"Pendant","weight":0.0168623,"wikipedia_article":"http://en.wikipedia.org/wiki/Pendant"},{"name":"Incorporation (business)","weight":0.0168623,"wikipedia_article":"http://en.wikipedia.org/wiki/Incorporation_(business)"},{"name":"Titer","weight":0.0168623,"wikipedia_article":"http://en.wikipedia.org/wiki/Titer"},{"name":"Resource","weight":0.0168623,"wikipedia_article":"http://en.wikipedia.org/wiki/Resource"},{"name":"Psychological evaluation","weight":0.0168623,"wikipedia_article":"http://en.wikipedia.org/wiki/Psychological_evaluation"},{"name":"Systematics","weight":0.0147415,"wikipedia_article":"http://en.wikipedia.org/wiki/Systematics"},{"name":"Due process","weight":0.0147415,"wikipedia_article":"http://en.wikipedia.org/wiki/Due_process"},{"name":"Base (chemistry)","weight":0.0147415,"wikipedia_article":"http://en.wikipedia.org/wiki/Base_(chemistry)"},{"name":"Regulation","weight":0.0147415,"wikipedia_article":"http://en.wikipedia.org/wiki/Regulation"},{"name":"Document","weight":0.0147415,"wikipedia_article":"http://en.wikipedia.org/wiki/Document"},{"name":"Professional revolutionaries","weight":0.0147415,"wikipedia_article":"http://en.wikipedia.org/wiki/Professional_revolutionaries"}]}
